Live
AgilentAgilent Technologies (A) Announces Amendments to Corporate Gover - GuruFocusThermo FisherThermo Fisher’s Fluid Ease Pro ClipTip puts a touchscreen on the electronic pipette - R&D WorldAgilentAgilent, Axion End Cell Analysis IP Suit After Jury Selection - Law360BioWorldG2Gbio secures license deal, ₩20B investment from Samsung EpisAgilentDirector George Scangos gets 3,215 Agilent (NYSE: A) shares - Stock TitanFierceBiotechNIH grant cuts hit women, early-career scientists the hardest: analysisFierceBiotechMRI providers keep eye on rising helium prices amid war in IranEndpoints NewsNovartis to invest $480M in China following AstraZeneca and Lilly pledgesEndpoints NewsFDA posts photos of Indian drugmaking facility cited in warning letterIlluminaIllumina : CSR Report (2025 illumina france gender pay gap english) - marketscreener.comRoche MediaMinistry of Health and Population and Roche Diagnostics sign MoU to advance digital pathology in Egypt - Intelligent CIOBioPharma DiveApogee strengthens case for longer-lasting eczema drug
BioWorld Mar 23, 2026

G2Gbio secures license deal, ₩20B investment from Samsung Epis

G2Gbio secures license deal, ₩20B investment from Samsung Epis

Original
Body unavailable. Use the original source.

Directory

59 All